Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
OTONOMY, INC. (OTIC)
|
Add to portfolio |
|
|
|
| Price: |
$2.17
| | Metrics |
| OS: |
57.0
|
M
| |
-166
|
% ROE
|
| Market cap: |
$124
|
M
| |
|
|
|
Net cash:
|
$53.1
|
M
| |
$0.93
|
per share
|
|
EV:
|
$70.5
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($42.6)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
($0.79)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.1 | 0.3 | 0.6 | 0.7 | 1.2 | 0.7 | 0.0 | 0.0 |
| Revenue growth | -54.2% | -54.5% | -19.5% | -39.7% | 81.0% | | | |
| Cost of goods sold | 0.4 | 1.2 | 0.9 | 0.9 | 3.1 | 1.7 | 0.0 | 0.0 |
| Gross profit | -0.2 | -0.9 | -0.3 | -0.2 | -1.9 | -1.0 | 0.0 | 0.0 |
| Gross margin | -196.0% | -335.2% | -52.0% | -27.0% | -150.6% | -143.6% | | |
| Selling, general and administrative | 49.4 | 42.6 | 44.5 | 20.0 | 46.8 | 49.8 | 23.2 | |
| Research and development | | | | 31.8 | 42.7 | 60.7 | 38.8 | 31.8 |
| General and administrative | | | | | | | | 7.8 |
| EBIT | -52.7 | -46.0 | -44.5 | -52.1 | -91.4 | -111.5 | -62.0 | -39.6 |
| EBIT margin | -42189.6% | -16840.7% | -7423.8% | -6987.0% | -7394.9% | -16322.3% | | |
| Pre-tax income | -51.2 | -44.7 | -44.7 | -50.4 | -90.1 | -110.6 | -61.7 | -42.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | | | |
| Net income | -51.2 | -44.7 | -44.7 | -50.4 | -90.1 | -110.6 | -61.7 | -42.9 |
| Net margin | -40944.8% | -16385.0% | -7445.8% | -6760.8% | -7292.1% | -16190.8% | | |
| |
| Diluted EPS | ($0.81) | ($1.10) | ($1.45) | ($1.65) | ($2.97) | ($3.69) | ($2.57) | ($5.46) |
| Shares outstanding (diluted) | 63.4 | 40.8 | 30.7 | 30.6 | 30.3 | 30.0 | 24.0 | 7.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|